Janney Montgomery Scott downgraded PLx Pharma (NASDAQ: PLXP) from Buy to Neutral with a price target of $6.00 (from $14.00).Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE